MAUDE MDR 9131457

MDR report key
9131457
Report number
3004154314-2019-00011
Event key
0
Event type
3
Date received
2019-09-27
Adverse event
3
Product problem
3
Patients in event
0
Reporter occupation
3
Health professional
3
Initial report to FDA
3
Event location
3

Manufacturer Contact#

Contact
MR. PHANI PUPPALA
Address
28 FORGE PARKWAY FRANKLIN, MA 02038 US
Phone
508-508-5085
Report source
M
Manufacturer link flag
Y

Devices#

Seq, Brand, Generic table
SeqBrandGenericManufacturerProduct codeModelCatalogLotPMA510(k)ImplantEvaluatedAvailability
1ARTHROSURFACE TOEMOTIONARTHROSURFACE? TOTAL TOE - PROXIMAL PHALANX IMPLANTARTHROSURFACE, INC.LZJ9P15-PB01-A/ 9P15-S180-A75ID0208/ 75ID0219R N

Patients#

Sequence, Received, Treatment table
SequenceReceivedTreatmentOutcome
12019-09-2701. O

Event Narratives#

N

Patient 1

THE PATIENT HAD PROVIDED COPIES OF X-RAYS ON REQUEST, WHICH CONFIRMED LOOSENING OF THE PHALANGEAL COMPONENT IN THE BONE. THE EXACT CAUSE OF REPORTED LUCENCY IS UNKNOWN. AS A PART OF THE INVESTIGATION, INCOMING AND FINAL INSPECTION RECORDS (DHRS) OF THE LOTS IN QUESTION WERE REVIEWED AND NO DISCREPANCIES WERE NOTED. ALL PARTS WERE BUILT TO SPECIFICATION AND NON-CONFORMING PARTS WERE APPROPRIATELY IDENTIFIED AND DISPOSITIONED ACCORDINGLY. THE INSTRUCTIONS FOR USE (IFU) DOCUMENT STATES THAT THIS TYPE OF EVENT CAN OCCUR, AND ALL RISKS ARE ADDRESSED IN THE RISK DOCUMENTATION. A VALID ROOT CAUSE CANNOT BE ESTABLISHED BASED ON AVAILABLE INFORMATION. SEVERAL FACTORS SUCH AS STRESS/ PHYSICAL LOADS ON THE IMPLANTS, VASCULARITY OF THE IMPLANTATION SITE, SURGICAL TECHNIQUES EMPLOYED DURING IMPLANTATION, PATIENT FACTORS (SUCH AS AGE, CURRENT STATE OF THE IMMUNE SYSTEM, BONE QUALITY, AND SENSITIVITY TO DEVICE MATERIALS), AND PATIENT POST-OP COMPLIANCE TO REHABILITATION PROCEDURES ETC. CAN HAVE IMPACT ON THE FUNCTIONAL EFFECTIVENESS OF THE IMPLANTED DEVICES. THE PATIENT WAS ADVISED TO GET A FULL WORK UP DONE BY A SURGEON WHICH MAY HELP IN DETERMINATION OF UNDERLYING CAUSE(S) OF REPORTED LOOSENING. A SECOND MDR WAS FILED FOR THE PATIENT'S OTHER TOEMOTION DEVICE (MDR #: 3004154314-2019-00012). IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, IT WILL BE REVIEWED FOR REPORTABILITY AND SUBMITTED VIA A SUPPLEMENTAL MDR. BELOW IS THE PART AND LOT INFORMATION OF THE PATIENT'S FIRST TOEMOTION IMPLANT. PN: 9P15-S180-A, LOT # 75ID0219, MFG. DATE: 09-2014, EXP. DATE: 09-2019. PN: 9P15-PB01-A, LOT # 75ID0208, MFG. DATE: 11-2014, EXP. DATE: 11-2019.

D

Patient 1

ARTHROSURFACE WAS INFORMED OF THIS EVENT BY THE PATIENT THROUGH A BLOGPOST ON THE WEBSITE. THE PATIENT RECEIVED BILATERAL TOEMOTION IMPLANTS IN 2015 SIX MONTHS APART. AT 3 YEARS POST-OP, THE TREATING SURGEON RECOMMENDED SILICONE IMPLANTS AND BONE GRAFTS TO THE PATIENT AFTER NOTICING LUCENCY AROUND THE PHALANGEAL IMPLANTS. PATIENT ALSO REPORTED THAT AN MD RECOMMENDED CONSIDERING FUSION IN A RECENT VISIT.